Private Market View

Sofinnova Partners

Venture capital · Paris, France

AUM
$4.6B
Portfolio companies
58
Recorded deals
470
24 in last 12M
Last investment

Key facts

  • Sofinnova Partners is a venture capital firm based in Paris, France with 58 tracked portfolio companies.
  • Notable positions include DNA Script, Hemab Therapeutics Holdings, Galvanize Therapeutics, Artios, BrightHeart.

About Sofinnova Partners

Founded in 1972, Sofinnova Partners is a venture capital firm based in Paris, France. The firm prefers to invest in companies operating in the life sciences sector and primarily focuses on investing in the healthcare and sustainability sectors.

Free account
See the whole book
  • ·The book's top 25 — of 58 recorded positions
  • ·Watchlist + alerts for Sofinnova Partners's activity
Create free account
No card required

Portfolio, priced

58 companies · by our current valuations
CompanyValuationRole
DNA Script$659.7M
Hemab Therapeutics Holdings$386.9M
Galvanize Therapeutics$300.0M
Artios$260.3M
BrightHeart$234.8M
Mediar Therapeutics$230.0M
Noema Pharma$228.8M
Bioptimus$159.5M
NodThera$151.8M
Arzeda$149.5M
Latent Labs$139.9M
HAYA Therapeutics$115.5M
Mission Therapeutics$115.2M
Actithera$110.0M
CorWave$108.7M
+ 43 more companies · a free account shows the top of the book

Frequently asked

What companies does Sofinnova Partners invest in?
Sofinnova Partners has 58 recorded portfolio companies, including DNA Script, Hemab Therapeutics Holdings, Galvanize Therapeutics, Artios.
What is Sofinnova Partners's AUM?
Sofinnova Partners manages approximately $4.6B in assets.